Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-23-024390)

Filing Details

Accession Number:: 0001209191-23-024390
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2023-04-17 06:00:07
Reporting Period:: 2023-04-13

Accepted Time:: 2023-04-17 06:00:07
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1260990	Oncternal Therapeutics Inc.	ONCT	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1244823	B James Breitmeyer	12230 El Camino Real, Suite 230 San Diego CA 92130	Chief Executive Officer	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2023-04-13	100,000	$0.29	146,544	No	4	P	Indirect	By Family Trust
Common Stock	Acquisiton	2023-04-14	47,750	$0.30	194,294	No	4	P	Indirect	By Family Trust
Common Stock	Acquisiton	2023-04-14	2,250	$0.29	196,544	No	4	P	Indirect	By Family Trust

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	By Family Trust
No	4	P	Indirect	By Family Trust
No	4	P	Indirect	By Family Trust

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	541,981	Direct
Common Stock	23,918	Indirect	By Spouse
Common Stock	733	Indirect	By Child